(S1 (S (NP (NP (NP (JJ Oncogenic) (JJ epidermal) (NN growth) (NN factor) (NN receptor) (NNS mutants)) (PP (IN with) (NP (JJ tandem) (NN duplication)))) (: :) (NP (NP (NN gene) (NN structure)) (CC and) (NP (NP (NNS effects)) (PP (IN on) (NP (NN receptor) (NN function))))) (. .))))
(S1 (S (S (NP (NP (DT A) (NN number)) (PP (IN of) (NP (NP (NP (JJ epidermal) (NN growth) (NN factor) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN EGFR)) (-RRB- -RRB-))) (NN deletion) (NNS mutants)))) (VP (VBP have) (VP (VBN been) (VP (VBN identified) (PP (IN in) (NP (NNS gliomas))) (, ,) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (DT the) (NN EGFR) (NN gene)) (VP (VBZ is) (ADVP (RB frequently)) (VP (VP (VBN amplified)) (CC and) (VP (VBN rearranged)))))))))) (. .)))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (ADVP (RB previously)) (VP (VBN characterized) (NP (NP (DT the) (NN structure)) (PP (IN of) (NP (NP (DT a) (NN gene)) (PP (IN in) (NP (NN A-172) (JJ human) (NN glioma) (NNS cells))) (SBAR (WHNP (WDT that)) (S (VP (VBZ encodes) (NP (NP (DT a) (JJ 190-kDa) (NN EGFR) (NN mutant)) (PP (IN with) (NP (NP (JJ tandem) (NN duplication)) (PP (IN of) (NP (DT the) (NP (NP (NP (NN tyrosine) (NN kinase)) (PRN (-LRB- -LRB-) (NP (NN TK)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ calcium-mediated) (NN internalization)) (PRN (-LRB- -LRB-) (NP (NNP CAIN)) (-RRB- -RRB-)))) (NNS domains))))))))))))))) (. .)))
(S1 (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP describe) (NP (NP (NP (DT a) (JJ 185-kDa) (JJ tandem) (NN duplication) (NN mutant)) (PRN (-LRB- -LRB-) (NP (NN TDM)) (-RRB- -RRB-))) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (VP (VBN expressed) (PP (IN in) (NP (NP (NN KE)) (CC and) (NP (NN A-1235) (NN glioma) (NNS cells)))) (, ,) (PP (IN along) (PP (IN with) (NP (NP (JJ certain) (JJ functional) (NNS characteristics)) (PP (IN of) (NP (DT the) (NNS mutants)))))))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (JJ corresponding) (NNS transcripts)) (PP (IN in) (NP (NP (NNS KE)) (CC and) (NP (NN A-1235) (NNS cells))))) (VP (VBP contain) (NP (NP (CD 1053) (JJ additional) (NNS nucleotides)) (VP (VBG representing) (NP (NP (DT an) (JJ in-frame) (NN duplication)) (PP (IN of) (NP (NNS exons) (QP (CD 18) (IN through) (CD 25)))) (SBAR (WHNP (WDT which)) (S (VP (VBP encode) (NP (NP (DT the) (JJ entire) (NN TK) (NN region)) (CC and) (NP (NP (DT a) (NN portion)) (PP (IN of) (NP (DT the) (NNP CAIN) (NN domain))))))))))))) (. .)))
(S1 (S (PP (IN As) (PP (IN with) (NP (NP (NN duplication)) (PP (IN of) (NP (NP (DT the) (JJ entire) (NN TK/CAIN) (NN region)) (PRN (-LRB- -LRB-) (NP (NNS exons) (NP (CD 18-26))) (-RRB- -RRB-)))) (PP (IN in) (NP (NN A-172) (NNS cells)))))) (, ,) (NP (NP (NN duplication)) (PP (IN of) (NP (NNS exons) (CD 18-25)))) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (DT a) (JJ specific) (JJ genomic) (NN rearrangement)) (PP (IN between) (NP (JJ flanking) (NNS introns))))))) (. .)))
(S1 (S (S (NP (JJ Involved) (NNS introns)) (VP (VBP contain) (NP (NP (NN homology)) (PP (TO to) (NP (NP (NP (NP (NN recombination) (NN signal) (NN sequence)) (PRN (-LRB- -LRB-) (NP (NN RSS)) (-RRB- -RRB-))) (NNS heptamers)) (ADJP (JJ present) (PP (IN in) (NP (NP (DT the) (NN V-LRB-D-RRB-J) (NN region)) (PP (IN of) (NP (DT the) (NN T) (NN lymphocyte) (NN receptor) (NN gene))))))))))) (. .)))
(S1 (S (S (PP (IN In) (NP (VBN defined) (NN medium))) (, ,) (NP (DT both) (JJ oncogenic) (NN TDM)) (VP (VBP are) (ADVP (RB constitutively)) (VP (VP (VBN autophosphorylated)) (CC and) (VP (ADVP (RB inefficiently)) (VBN downregulated))))) (. .)))
(S1 (S (S (NP (JJ High-affinity) (NN binding)) (VP (VBZ is) (VP (VBN reduced) (PP (IN in) (NP (NN EGFR.TDM/18-26)))) (, ,) (SBAR (IN although) (S (NP (NP (DT the) (NN t1/2)) (PP (IN of) (NP (NN receptor) (NN internalization)))) (VP (VBZ is) (RB not) (ADJP (JJ prolonged))))))) (. .)))
